Comparison of the half-lives and regeneration rates of blood clotting factors II, VII, and X in anticoagulant-resistant and susceptible Norway rats (Rattus norvegicus Berk.)

Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology

Volumn 122, Issue 3, 1999, Pages 307-316

  Kerins, Gerard M ^a   MacNicoll, Alan D ^a  

^a CENTRE FOR ENVIRONMENT   (United Kingdom)

Author keywords

Anticoagulant resistance; Chromogenic assays; Clotting factors; Rats; Rodents

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BRODIFACOUM; DIFENACOUM; FARNOQUINONE; MENADIONE; PROTHROMBIN; VITAMIN K GROUP; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BIOSYNTHESIS; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REGENERATION; VITAMIN K DEFICIENCY;

ANIMALS; ANTICOAGULANTS; FACTOR VII; FACTOR X; FEMALE; HALF-LIFE; MALE; PROTHROMBIN; RATS; RATS, WISTAR; RODENTICIDES;

EID: 0033059542     PISSN: 07428413     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0742-8413(98)10128-7     Document Type: Article

References (25)

1. Cowan D, Dunsford G, Gill E, Jones A, Kerins G, MacNicoll A, Quy R The impact of resistance on the use of second-generation anticaogulants against rats on farms in southern England. Pestic Sci. 43:1995;83-93.
2. Dialameh GH Stereobiochemical aspects of warfarin isomers for inhibition of enzymatic alkylation of menaquinone-0 to menaquinone-4 in chick liver. Internat J Vit Nutr Res. 48:1978;131-135.
3. Gill JE, Kerins GM, MacNicoll AD Inheritance of low grade brodifacoum resistance in the Norway rat. J Wildl Manage. 56(4):1992;809-816.
4. Gill JE, Kerins GM, Langton SD, MacNicoll AD The development of a blood clotting response test for discriminating between difenacoum-resistant and susceptible Norway rats (Rattus norvegicus Berk.). Comp Biochem Physiol. 104C:1993;29-36.
5. Gill JE, Kerins GM, Langton SD, MacNicoll AD Blood-clotting response test for bromadiolone resistance in Norway rats. J Wildl Manage. 58(3):1994;454-461.
6. Greaves JH, Ayres PB Heritable resistance to warfarin in rats. Nature. 215:1967;877-878.
7. Greaves JH, Cullen-Ayres PB. Genetics of difenacoum resistance in the rat. In: Suttie JW, editor. Seventeenth Steenbock Symposium on Current Advances in Vitamin K Research. New York: Elsevier, 1988:389-397.
8. Greaves JH, Shepherd DS, Gill JE An investigation of difenacoum resistance in Norway rat populations in Hampshire. Ann Appl Biol. 100:1982;581-587.
9. Harauchi T, Takano K, Matsura M, Yoshizaki T Liver and plasma levels of descarboxy prothrombin (PIVKA II) in vitamin K deficiency in rats. Jpn J Pharmacol. 40:1986;491-499.
10. Hemker HC, Lindhout MJ, Reekers PPM. Demonstration of three proteins induced by vitamin K absence (PIVKAS). Thromb Diath Haemorrh 1974;59 Suppl:45-52.
11. Kelly MJ, Johnston A, MacNicoll AD. Pharmacokinetics at a discriminating dose of the cis and trans diastereomers of difenacoum in male and female warfarin-resistant and susceptible rats (submitted).
12. MacNicoll AD. The role of altered vitamin K metabolism in anticoagulant resistance in rodents. In: Suttie JW, editor. Seventeenth Steenbock Symposium on Current Advances in Vitamin K Research. New York: Elsevier, 1988:407-417.
13. Martin AD, Steed LC, Redfern R, Gill JE, Huson LW Warfarin resistance genotype determination in the Norway rat (Rattus norvegicus). Lab Anim. 13:1979;209-214.
14. Owren PA Thrombotest: a new method for controlling anticoagulant therapy. Lancet. 2:1959;754-758.
15. Price PA. Bone gla protein and matrix gla protein: identification of the probable structures involved in substrate recognition by the γ-carboxylase and discovery of tissue differences in vitamin K metabolism. In: Suttie JW, editor. Seventeenth Steenbock Symposium on Current Advances in Vitamin K Research. New York: Elsevier, 1988:295-273.
16. Pyörälä K. Determinants of the clotting factor response to warfarin in the rat. Academic dissertation, Finnish Red Cross Society and the University of Helsinki, Finland, 1965.
17. Redfern R, Gill JE The development and use of a test to identify resistance to the anticoagulant difenacoum in the Norway rat (Rattus norvegicus). J Hyg. 81:1978;427-431.
18. Stenflo J, Suttie JW Vitamin K-dependent formation of γ-carboxyglutamic acid. Ann Rev Biochem. 46:1977;157.
19. Suttie JW, Jackson CM. Prothrombin structure, activation, and biosynthesis. Physiol Rev 1977;57.
20. 3H in the rat. Biochemistry. 8:1969;1141-1146.
21. Talstad I Which coagulation factors interfere with the one-stage prothrombin time? Haemostasis. 23:1993;19-25.
22. Thijssen HH, Baars LG Tissue distribution of selective warfarin binding sites in the rat. Biochem Pharmacol. 42(11):1991;2181-2186.
23. Ulrich M. In vitro modification of synthetic peptides containing the γ-glutamyl carboxylation recognition site. In: Enzyme/substrate interactions of the vitamin K-dependent carboxylase. Ph.D. thesis, University of Limburg ISBN 90-5291-065-0. 1991;57-69.
24. Van-Haarlem LJM, Ulrich MMW, Hemker HC, Soute BAM, Vermeer C Isolation and partial characterization of a vitamin K-dependent carboxylase from bovine aortae. Biochem J. 245:1987;251-255.
25. Zimmermann A, Matschiner JT Biochemical basis of hereditary resistance to warfarin in the rat. Biochem Pharmacol. 23:1974;1033-1040.